Novel approaches to assessing renal function in cirrhotic liver disease

Hepatology Research

Volumn 37, Issue 9, 2007, Pages 667-672

  Portal, Andrew J ^a   Austin, Mark ^a   Heneghan, Michael A ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Asymmetrical dimethyl arginine; Biomarkers; Cystatin C; Neutrophil gelatinase associated lipocalin; Renal function

Indexed keywords

ACETYLGLUCOSAMINIDASE; BIOCHEMICAL MARKER; CORTICOSTEROID; CYCLOSPORIN; CYSTATIN C; DIMETHYL ARGININE; GLUTATHIONE TRANSFERASE; KIDNEY INJURY MOLECULE 1 PROTEIN; LIPOCALIN; MEMBRANE PROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NITRIC OXIDE SYNTHASE INHIBITOR; SODIUM PROTON EXCHANGE PROTEIN 3; UNCLASSIFIED DRUG; UREA;

ACUTE KIDNEY TUBULE NECROSIS; BLOOD LEVEL; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULUS; HEPATORENAL SYNDROME; HUMAN; IMMUNOASSAY; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; LIVER CIRRHOSIS; LIVER FAILURE; NEPHELOMETRY; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; REVIEW; SENSITIVITY ANALYSIS; UREA BLOOD LEVEL; UREA CYCLE;

EID: 34447331656     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00086.x     Document Type: Review

References (34)

1. Moreau R, Lebrec D. Acute renal failure in patients with cirrhosis: perspectives in the age of MELD. Hepatology 2003; 37: 233-43.
2. Gerbes AL, Gulberg V, Bilzer M, Vogeser M. Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver. Gut 2002; 50: 106-10.
3. Caregaro L, Menon F, Angeli P et al. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med 1994; 154: 201-5.
4. Skluzacek PA, Szewc RG, Nolan CR, Riley DJ, Lee S, Pergola PE. Prediction of GFR in liver transplant candidates. Am J Kidney Dis 2003; 42: 1169-76.
5. Laterza OF, Price CP, Scott MG. Cystatin C: An improved estimator of glomerular filtration rate? Clin Chem 2002; 48: 699-707.
6. Herget-Rosenthal S, Marggraf G, Husing J et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004; 66: 1115-22.
7. Woitas RP, Stoffel-Wagner B, Flommersfeld S et al. Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis. Clin Chem 2000; 46: 712-15.
8. Chu SC, Wang CP, Chang YH et al. Increased cystatin C serum concentrations in patients with hepatic diseases of various severities. Clin Chem Acta 2004; 341: 133-8.
9. Orlando R, Mussap M, Plebani M et al. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 2002; 48: 850-8.
10. Schuck O, Gottfriedova H, Maly J et al. Glomerular filtration rate assessment in individuals after orthotopic liver transplantation based on serum cystatin C levels. Liver Transpl 2002; 8: 594-9.
11. Biancofiore G, Pucci L, Cerutti E et al. Cystatin C as a marker of renal function immediately after liver transplantation. Liver Transpl 2006; 12: 285-91.
12. Samyn M, Cheeseman P, Bevis L et al. Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl 2005; 11: 344-9.
13. Knight EL, Verhave JC, Spiegelman D et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kid Int 2004; 65: 1416-21.
14. Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis 2001; 37: 79-83.
15. Akbari A, Lepage N, Keely E et al. Cystatin-C and beta trace protein as markers of renal function in pregnancy. BJOG 2005; 112: 575-8.
16. Cimerman N, Brquljan PM, Krasovec M, Suskovic S, Kos J. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. Clin Chim Acta 2000; 300: 83-95.
17. Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV. Urinary kidney injury molecule-1: A sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 2006; 290: F517-29.
18. Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV. Kidney injury molecule-1: A tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol 2004; 286: F552-63.
19. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney injury molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int 2002; 62: 237-44.
20. Mishra J, Ma Q, Prada A et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003; 14: 2534-43.
21. Yang J, Goetz D, Li JY et al. An iron delivery pathway mediated by a lipocalin. Mol Cell 2002; 10: 1045-56.
22. Mori K, Lee HT, Rapoport D et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005; 115: 610-21.
23. Mishra J, Dent C, Tarabishi R et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365: 1231-8.
24. Wang T, Yang CL, Abbiati T et al. Mechanism of proximal tubule bicarbonate absorption in NHE3 null mice. Am J Physiol 1999; 277: F298-302.
25. McKee JA, Kumar S, Ecelbarger CA, Fernandez-Llama P, Terris J, Knepper MA. Detection of Na(+) transporter proteins in urine. J Am Soc Nephrol 2000; 11: 2128-32.
26. du Cheyron D, Daubin C, Poggioli J et al. Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. Am J Kidney Dis 2003; 42: 497-506.
27. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-5.
28. Fleck C, Schweitzer F, Karge E, Busche M, Stein G. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases. Clin Chim Acta 2003; 336: 1-12.
29. Nijveldt RJ, Teerlink T, Siroen MP, van Lambalgen AA, Rauwerda JA, van Leeuwen PA. The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA). Clin Nutr 2003; 22: 17-22.
30. Siroen MP, van der Sijp JR, Teerlink T, van Schaik C, Nijveldt RJ, van Leeuwen PA. The human liver clears both asymmetric and symmetric dimethylarginine. Hepatology 2005; 41: 559-65.
31. Lluch P, Mauricio MD, Vila JM et al. Accumulation of symmetric dimethylarginine in hepatorenal syndrome. Exp Biol Med (Maywood) 2006; 231: 70-5.
32. Lluch P, Torondel B, Medina P et al. Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis. J Hepatol 2004; 41: 55-9.
33. Sundberg AG, Appelkvist EL, Backman L, Dallner G. Urinary pi-class glutathione transferase as an indicator of tubular damage in the human kidney. Nephron 1994; 67: 308-16.
34. Westhuyzen J, Endre ZH, Reece G, Reith DM, Saltissi D, Morgan TJ. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transpl 2003; 18: 543-51.